Passa alla casella di ricercaPassa alla navigazionePassa al contenuto principale

Prebiotics and probiotics as potential therapy for cognitive impairment

*Corresponding author for this work
Prodotto della ricerca:
Contribution to journal
Article
Peer review

Publication Information

Tipo di output

Prodotto della ricerca:
Contribution to journal
Article
Peer review

Lingua originale

English

Numero dell’articolo

109410

Rivista (volume, numero edizione)

Medical Hypotheses (Volume 134)

Attività cardine della pubblicazione

  • Published - 01/01/2020

Stato pubblicazione

Published - 01/01/2020

ISSN

0306-9877

Publication IDs

  • Scopus: 85073258494
  • PubMed: 31627123

Abstract

Cognitive functions, such as learning and memory, may be impaired during aging. Age-related cognitive impairment is associated with selective neuronal loss, oxidative changes that lead to microglia activation and neuroinflammation. In addition, it is associated to alteration reduction in trophic factors affecting neurogenesis and synaptic plasticity. In recent years, attention has been paid to the relationship between gut microbiota and brain. In aging, there is an alteration in microbiota, gut microbiota diversity is perturbed with an increase in pathogenic bacteria at the expense of beneficial ones. Dysbiosis may lead to chronic inflammation, and a decrease in bacteria metabolites such as short-chain fatty acids which have been related to an upregulation of neurotrophic factors. Supplementation with prebiotics and probiotics can modulate gut microbiota, returning it to a more physiological state; thus, they may be considered as a possible treatment for age-related cognitive impairment.

Publication metrics

Metriche

SciVal
FWCI
1.49

PlumX, si apre in una nuova scheda

Social media
30
Citation count
48
Captures
172